The cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway has gained significant attention due to its ability to activate the production of type I interferon, thereby enhancing anti-tumor immune responses (45). This evidence concerns the gene STING1 and neoplasm.